Use of secondary prevention medication for patients with a final diagnosis of acute coronary syndrome
| ACEI | β Blocker | Statin | Aspirin | |
|---|---|---|---|---|
| ACEI, angiotensin converting enzyme inhibitor. | ||||
| 2000–1 | 12336/19757 (62.4%) | 13568/17782 (76.3%) | 13678/196432 (69.6%) | 18722/20954 (89.3%) |
| 2001–2 | 34215/49007 (69.8%) | 33745/41 744 (80.8%) | 38802/49 486 (78.4%0 | 46037/50793 (90.6%) |
| 2002–3 | 44507/61472 (72.4%) | 42401/51 353 (82.6%) | 52078/62 164 (83.8%) | 56695/62876 (90.2%) |
| Difference (percentage points) | 10 | 6.3 | 14.2 | 0.9 |
| 95% CI 2000–1 and 2002–3 | 9.2 to 10.7, p<0.0001 | 5.6 to 7.0, p<0.0001 | 13.4 to 14.8, p<0.0001 | 0.3 to 1.3. p<0.001 |